Skip to content

Skeletal Muscle Wasting and Insulin Resistance Following Surgical Stress

Does Surgical Stress Impair Skeletal Muscle Protein and Carbohydrate Metabolism?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01134809
Acronym
SIRSS
Enrollment
15
Registered
2010-06-02
Start date
2010-05-31
Completion date
2013-05-31
Last updated
2015-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance

Keywords

Major abdominal surgery

Brief summary

Background: Skeletal muscle wasting or decrease in muscle mass occurs as a result of alteration in the body's mechanisms to make or break muscle protein. In animal models, the pathway termed as 'ubiquitin-proteasome pathway' (UPP) is primarily responsible for the regulation of skeletal muscle protein loss in wasting conditions and during infection(sepsis). Skeletal muscle wasting is noticed in patients having major surgery due to the inflammatory reaction triggered by special group of proteins called cytokines (inflammatory proteins), resulting in reduced muscle strength, impaired capacity to fight infections, change in bowel function, increased clinical complications and prolonged recovery. Major surgery also leads to decreased sensitivity to hormone known as insulin, resulting in 'diabeteslike'state. We hypothesize that susceptibility of patients undergoing major abdominal surgery, to skeletal muscle wasting and insulin resistance, is determined by stress response to surgery over time, leading to changes in the pathways that make or break muscle protein, namely the Akt/Foxo signalling and UPP. Therefore, the aim of this study is to establish the underlying mechanisms of skeletal muscle wasting and insulin resistance in patients undergoing major abdominal surgery.

Detailed description

Experimental plan Fifteen adult patients undergoing major open elective abdominal surgery will be included in this nonrandomized study. Objectives: 1. To study the expression proteins and metabolites involved in UPP mediated protein degradation, in blood and muscle biopsy samples. 2. To correlate the effects of surgery on the release of bacteria in blood from the bowel. The analysis of the samples will include the following techniques, namely, RTPCR, ELISA, western blotting and metabolomics. Establishing the association between these signaling mechanisms and expression of the individual proteins secondary to inflammation following surgery and infection would enable application of suitable therapeutic strategies that could reduce the inflammatory response to benefit all patients undergoing surgery.

Interventions

PROCEDUREMajor abdominal surgery

All adult patients having major abdominal surgery

Sponsors

University of Nottingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All adult patients undergoing major open elective gastrointestinal surgery lasting 3 hours or more will be eligible for the study.

Exclusion criteria

* Patients who are: 1. undergoing emergency surgery 2. suffering from chronic illness, (e.g. diabetes) or other debilitating diseases 3. on long term anti-inflammatory drugs, (e.g. NSAIDS, Steroids, immunosuppressant) 4. on long term antibiotics 5. on statins 6. on full therapeutic dose of anticoagulants, or aspirin \> 325 mg/day, clopidogrel \> 75 mg/day 7. suffering from bleeding diathesis 8. unable to give consent 9. pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frame
postoperative insulin resistanceFirst week following surgery

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026